About Ster Chem
Ster Chem is a company based in India founded in 2010. It operates as a B2B. The company has 119 employees. Ster Chem operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Haryana, India
- Employees 119
- SectorsHealthcare
- Website sterchem.com
- Legal Name Sterkem Pharma Private Limited
- Date of Incorporation 28 Mar, 2002
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹12.83 Cr
FY 2025 · +2% YoY
- Net Loss-₹0.09 Cr
FY 2025 · -1% margin
- EBITDA₹0.00 Cr
FY 2025 · 0% margin
- Employee Count119
Associated legal entities of Ster Chem
Ster Chem operates through Sterkem Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sterkem Pharma Private Limited CIN U51909MH2002PTC135324 | Active | 28 Mar 2002 | Mumbai, Maharashtra | ₹12.8 Cr | 119 | 3 | View details |
Board of directors of Sterkem Pharma Private Limited (Ster Chem)
Sterkem Pharma Private Limited is the primary company behind Ster Chem. The board of Sterkem Pharma Private Limited currently have 3 directors; the longest-serving is Ajit Naginbhai Desai, appointed in 2002. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ajit Naginbhai Desai DIN 01153127 | Director | 28 Mar 2002 | 24 yrs 6 mo | Sterkem Pharma Private Limited |
| Heena Mayank Patel DIN 01147552 | Director | 01 Apr 2015 | 11 yrs 6 mo | Sterkem Pharma Private Limited |
| Sheela Harish Merchant DIN 08701866 | Director | 01 Sep 2025 | 1 yr 1 mo | Sterkem Pharma Private Limited |
Financials of Ster Chem
Figures of Sterkem Pharma Private Limited, the primary company behind Ster Chem, for FY 2025. Revenue was ₹12.83 Cr (+2% year on year). Net loss was -₹0.09 Cr (-1% margin). EBITDA was ₹0.00 Cr (0% margin). Revenue has grown at a compounded annual rate of +4% over three years and +3% over five years.
- ₹12.83 CrRevenue · FY 2025 · +2% YoY
- -₹0.09 CrNet loss · -1% margin
- ₹0.00 CrEBITDA · 0% margin
- ₹0.02 CrPaid-up capital
- 119Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +3%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sterkem Pharma Private Limited are on its company page.
Detailed financial statements for Ster Chem
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Ster Chem
Ster Chem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.7M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.0M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.9M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.2M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed competitors of Ster Chem
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Ster Chem
10 companies that operate in the same segment as Ster Chem (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Ster Chem
Ster Chem was founded in 2010.
Ster Chem is headquartered in India. It is registered at Haryana, India.
Ster Chem has 119 employees.
The primary company behind Ster Chem, Sterkem Pharma Private Limited, reported revenue of ₹12.83 Cr for FY 2025, up 2% year on year.
Ster Chem ster chem is a cdmo specializing in the manufacturing of active pharmaceutical ingredients through life sciences, producing pharmaceutical products, api manufacturing, and contract development. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Ster Chem's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Ster Chem operates through Sterkem Pharma Private Limited.
The legal entities of Ster Chem currently have 3 directors, including Heena Mayank Patel, Ajit Naginbhai Desai, Sheela Harish Merchant.